European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) ...

Medical Information
France
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you

This content is intended for French Healthcare Professionals. Would you like to proceed?

May 15, 2020

European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) to permit use of the product COMIRNATY COVID-19 mRNA Vaccine for active immunisation to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. During the initial pandemic stage, COMIRNATY COVID-19 mRNA Vaccine may also be distributed with the packaging with the name Pfizer-BioNTech COVID-19 Vaccine.